Physician profile
Asad Ansari
NPI 1053387175
$24,962.81
in general payments reported to CMS, 2019-2025
26 companies · $3,339 in 2025
The $3,339 reported for 2025 was more than what 94% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $62.32 · 2021: $511 · 2022: $293 · 2023: $7,554 · 2024: $13K · 2025: $3,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Consulting Fee: $6,656 · Food and Beverage: $3,473 · Travel and Lodging: $2,189 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,232.00 |
| Consulting Fee | $6,656.00 |
| Food and Beverage | $3,472.68 |
| Travel and Lodging | $2,189.47 |
| Education | $189.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $20,880.74 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $911.44 | 2019-2025 | Fasenra, Tezspire |
| Jazz Pharmaceuticals INC. | $685.31 | 2022-2025 | |
| Glaxosmithkline, LLC. | $602.92 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $265.39 | 2019-2025 | Dupixent |
| Harmony Biosciences LLC | $236.40 | 2024-2025 | |
| Inspire Medical Systems, INC. | $187.92 | 2023 | Inspire |
| Genentech USA, INC. | $187.38 | 2023-2025 | Xolair, Venclexta |
| Baxter Healthcare | $168.60 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Amgen INC. | $142.58 | 2024-2025 | Tezspire, Actimmune |
| Electromed, INC. | $92.74 | 2023-2025 | Smartvest |
| Genzyme Corporation | $89.98 | 2019-2025 | |
| Corium, LLC | $82.44 | 2023 | Azstarys |
| Sunovion Pharmaceuticals INC. | $76.84 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $55.35 | 2019-2022 | |
| Abbott Laboratories | $44.93 | 2023 | Freestyle Libre 2 |
| Neurelis, INC. | $31.43 | 2023 | Valtoco |
| Tris Pharma INC | $27.11 | 2019 | |
| Currax Pharmaceuticals LLC | $26.81 | 2019-2020 | |
| Qol Medical, LLC | $23.87 | 2024 | Sucraid |
| Insulet Corporation | $20.06 | 2019 | |
| Greenwich Biosciences, INC. | $18.36 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.44 | 2020 | |
| Nestle Healthcare Nutrition INC. | $17.26 | 2023 | |
| Resmed Corp | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.